Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Nucl Med. 2015 Jun 11;56(8):1246–1251. doi: 10.2967/jnumed.115.156216

FIGURE 6.

FIGURE 6

Biodistribution studies 24 h after injection confirmed our results, with PET/CT imaging demonstrating significantly higher accumulation of 64Cu-DOTA-antiperiostin-F(ab′)2 in TE-11 tumors and compared with negative control, TT tumors. PET probe is cleared from other organs and excreted through kidney and liver.